Breast Cancer Alliance Young Investigator Grants
Slots: 1 slot taken, 1 still available
Internal Deadline: Contact ORIF if interested.
External Deadline: July 23, 2021
Award Type: Grant
Anticipated Amount: $125,000 distributed over 2-year period.
Process for Limited Submissions: PIs must submit their application as a Limited Submission through the Office of Research Application Portal: https://research.usc.edu/usc-grants/.
Materials to submit include:
(1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
(2) CV – (5 pages maximum)
Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.
Link to Award: https://breastcanceralliance.org/how-to-apply
Who May Serve as PI: Applicants for the 2022 award must (i) not have held a tenure track faculty or tenure track research position for more than four years following completion of their training, as of March 1, 2022; (ii) not have been a principal investigator on an NIH R01 or equivalent national/international non-mentored award; and (iii) dedicate at least 50% of their work effort to research.
Purpose: This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support but who design and conduct their own independent research projects. To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists, including post docs, whose primary focus is breast cancer and who are in the early stages of their careers, to apply for funding for the Young Investigator Grant.
Budgetary Requirements: Indirect costs, which are included in the $125,000 award, must be limited to 8% of total direct costs.
Visit our Institutionally Limited Submission webpage for more updates and other announcements.